A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.
PHASE2
The purpose of this phase 2 dose-ranging trial is to investigate the effect...
Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation
PHASE2
The primary purpose of this trial is to compare three different doses of FE...
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
PHASE1
This is a phase 1b clinical trial with Choriogonadotropin beta (FE999302) a...